With the progress of COVID-19 vaccination programs worldwide, some new adverse events
associated with the available vaccines may unfold, especially in subpopulations, …

Background COVID-19 is speculated to increase the likelihood of relapsing-remitting
multiple sclerosis (RRMS) exacerbation. Objective To investigate the association between …

Studies among people with multiple sclerosis (pwMS) receiving disease-modifying therapies
(DMTs) have provided adequate evidence for an appraisal of COVID-19 vaccination …

As neurological complications associated with COVID-19 keep unfolding, the number of
cases with COVID-19-associated de novo movement disorders is rising. Although no clear …

Background Some current evidence is pointing towards an association between COVID-19
and worsening of multiple sclerosis (MS), stressing the importance of preventing COVID-19 …

Chimeric antigen receptor (CAR) regulatory T cell (Treg) therapy has approved promising in
murine experiments. It comprises from ex-vivo introduction of CARs to the Tregs of the …

Background Various studies indicated blunted humoral responses to COVID-19 mRNA and
viral vector vaccines among people with multiple sclerosis (pwMS) on sphingosine 1-…

To affirm the short-term safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among
people with multiple sclerosis (pwMS), 517 vaccinated and 174 unvaccinated pwMS were …

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a relatively unknown autoimmune
entity. Scant reports of post-infection/vaccination anti-NMDAR encephalitis exist. We, …

Background Our understanding of the spectrum of neurological manifestations associated
with COVID-19 keeps evolving. Reports of life-threatening neurological complications, such …